for better collaboration and faster study execution
\n<\/p>\n
Veeva Clinical Network will bring together sponsors, sites, and now patients
to accelerate clinical research
\n<\/em><\/p>\n
BARCELONA \u2014 2020 Veeva R&D Summit, Europe \u2014 19 May, 2020 \u2014<\/strong> Veeva Systems<\/a> (NYSE:VEEV) today announced Veeva Vault Site Connect<\/a>, a new application that connects sponsors and clinical research sites during trials. Vault Site Connect automates the flow of information between Vault Clinical<\/a> applications used by sponsors and Veeva SiteVault<\/a>, a compliant eISF application used by sites for source document management and remote monitoring. Now sponsors and sites can streamline information sharing for key trial processes, including feasibility, study document exchange, safety letter distribution, and subject status for faster study execution.<\/p>\n “There is a significant opportunity to speed information exchange throughout the clinical trial process,\u201d said Doug Schantz, member of SCRS leadership council and former head of U.S. site management and monitoring at AstraZeneca. \u201cVeeva Vault Site Connect will transform how sponsors and sites work together and help get studies up and running much faster.\u201d<\/p>\n Vault Site Connect seamlessly automates information flow across trial partners, processes, and systems. Sponsors can easily collect input from sites on study feasibility to spend less time coordinating surveys; accelerate document exchange and reconciliation between eTMF and eISF; quickly distribute safety letters to notify global sites and regulators of an adverse event; and get real-time information on the status of patients from enrollment through treatment \u2013 all with one application.<\/p>\n With Vault Site Connect, sponsors can improve site engagement by reducing the time and effort in exchanging clinical information. Now sites can focus less on administrative tasks and responding to information requests and more on execution and treating patients, improving overall study quality.<\/p>\n \u201cVeeva Vault Site Connect will eliminate the many portal interfaces, manual handoffs, and multiple steps it takes to share data with sponsors during a trial,\u201d said Tonya Yarbrough, director, Vanderbilt Institute for Clinical and Translational Research at Vanderbilt University Medical Center. \u201cNow the industry can leverage the same innovative Veeva Vault technology to drive greater efficiency and productivity during trials.\u201d<\/p>\n Vault Site Connect is part of the Veeva Clinical Network, a set of solutions that brings together sponsors, sites, and patients to accelerate clinical research. In addition to Vault Site Connect, Veeva today announced MyVeeva<\/a>, a multichannel patient portal for virtual visits and patient-centric trials. Together with Veeva Vault Clinical Suite<\/a>, Veeva is the first and only company providing solutions that help sponsors, sites, and patients share and view information during a clinical trial.<\/p>\n \u201cVeeva aims to improve efficiency and collaboration across the clinical trial ecosystem,\u201d said Rik Van Mol, vice president of strategy for Veeva Development Cloud. \u201cWith applications for sponsors, sites, and patients all part of the Veeva Clinical Network, we are providing a common way to connect and get real-time information throughout the course of a study.\u201d<\/p>\n Vault Site Connect is planned for availability in August 2020. To learn how Site Connect automates information sharing in clinical trials, register for an upcoming webinar on 23 June at veeva.com\/SiteConnectWebinar<\/a>, as well as the online Veeva R&D Summit<\/a>, 19-20 and 26 May, 2020.<\/p>\n Additional Information<\/strong> About Veeva Systems<\/strong> Forward-looking Statements<\/strong> ###<\/p>\n![\"\"\/](\"https:\/\/www.veeva.com\/wp-content\/uploads\/2020\/05\/Clinical-Network_v3-01.png\")
<\/a>
\nVeeva Vault Site Connect automates the flow of information
between clinical research sites and sponsors to speed trials.<\/span>\n<\/div>\n
\nFor more on Veeva Vault Site Connect, visit: veeva.com\/SiteConnectEU<\/a>
\nConnect with Veeva on LinkedIn: linkedin.com\/company\/veeva-systems<\/a>
\nFollow @veevasystems on Twitter: twitter.com\/veeva_eu<\/a>
\nLike Veeva on Facebook: facebook.com\/veevasystems<\/a><\/p>\n
\nVeeva Systems Inc. is the leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 850 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com\/eu<\/a>.<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of Veeva\u2019s products and services, the results from use of Veeva\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-K for the period ended January 31, 2020. This is available on the company\u2019s website at veeva.com<\/a> under the Investors section and on the SEC\u2019s website at sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.<\/p>\n